Engineered DNA vaccine protects against emerging Mayaro virus infection: New vaccine induces robust and specific immune responses and provides complete protection from disease in preclinical studies

A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat.